In 2011, acute and chronic pain affected 116 million people in the United States and costs the U.S. economy $635 billion every year (Institute of Medicine). According to the NIH, 40% patients seeking medical attention do so because of pain. Biological Coprocessors Inc. (BCP) has identified an objective signature of pain in the brain. BCP seeks Phase I funding to validate the objective electroencephalography (EEG) signature of pain and its intensity and develop a pain detection algorithm software. Our long-term goal (Phase 2, 3) is to develop and commercialize a user-friendly brain wave sensing device that utilizes our pain detection algorithm software to be used by DoD, physicians, pharmaceutical companies as well as consumers. The expected cost savings of using our device is to better diagnose and monitor pain levels, to decrease trauma recovery time, and improve pain management strategies. BCP?s team includes top experts in pain, neurosurgery, electrophysiology, computational neuroscience, military defense studies and medical product commercialization in the field of neuroscience.
Keywords: High-Density Eeg, Objective Pain Signature, Detection Algorithm
